These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 25706219)

  • 1. Treatment of personality disorder.
    Bateman AW; Gunderson J; Mulder R
    Lancet; 2015 Feb; 385(9969):735-43. PubMed ID: 25706219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of borderline personality disorder.
    Hirschfeld RM
    J Clin Psychiatry; 1997; 58 Suppl 14():48-52; discussion 53. PubMed ID: 9418746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacology of borderline personality disorder.
    Raj YP
    Curr Psychiatry Rep; 2004 Jun; 6(3):225-31. PubMed ID: 15142476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder.
    Hollander E
    J Clin Psychiatry; 1999; 60 Suppl 15():38-44. PubMed ID: 10418814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of outpatients with borderline personality disorder.
    Sweeney DR
    J Clin Psychiatry; 1987 Aug; 48 Suppl():32-7. PubMed ID: 2886495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medications in the treatment of borderline personality disorder 2006.
    Mercer D
    Curr Psychiatry Rep; 2007 Feb; 9(1):53-62. PubMed ID: 17257515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline states: pharmacotherapy and psychobiology of personality. A discussion of Soloff's article.
    Rosenberg R
    Acta Psychiatr Scand Suppl; 1994; 379():56-60. PubMed ID: 7912036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects.
    Coccaro EF
    J Clin Psychiatry; 1998; 59 Suppl 1():30-5; discussion 36-7. PubMed ID: 9448667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacology of borderline personality disorder: a review.
    Cowdry RW
    J Clin Psychiatry; 1987 Aug; 48 Suppl():15-25. PubMed ID: 2886493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?
    Abraham PF; Calabrese JR
    J Affect Disord; 2008 Nov; 111(1):21-30. PubMed ID: 18304647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends in the pharmacotherapy of personality disorders.
    Markovitz PJ
    J Pers Disord; 2004 Feb; 18(1):90-101. PubMed ID: 15061346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of borderline disorders.
    Soloff PH
    Compr Psychiatry; 1981; 22(6):535-43. PubMed ID: 6118234
    [No Abstract]   [Full Text] [Related]  

  • 13. [Update on Current Care Guideline: Borderline personality disorder].
    Korkeila J; Kantojärvi L; Koivisto M; Karlsson H; Keinänen M; Lindeman S; Nikkilä H; Stenberg JH; Taiminen T; Jousilahti P; Tuunainen A
    Duodecim; 2015; 131(16):1484-5. PubMed ID: 26485941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for patients with borderline personality disorder.
    Goldberg SC; Schulz SC
    Arch Gen Psychiatry; 1988 Feb; 45(2):195-6. PubMed ID: 2892479
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials.
    Lieb K; Völlm B; Rücker G; Timmer A; Stoffers JM
    Br J Psychiatry; 2010 Jan; 196(1):4-12. PubMed ID: 20044651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment of the personality disorders.
    Stein G
    Br J Psychiatry; 1992 Aug; 161():167-84. PubMed ID: 1355689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association.
    American Psychiatric Association Practice Guidelines
    Am J Psychiatry; 2001 Oct; 158(10 Suppl):1-52. PubMed ID: 11665545
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there any drug treatment of choice for the borderline patient?
    Soloff PH
    Acta Psychiatr Scand Suppl; 1994; 379():50-5. PubMed ID: 8010152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders.
    Herpertz SC; Zanarini M; Schulz CS; Siever L; Lieb K; Möller HJ; ;
    World J Biol Psychiatry; 2007; 8(4):212-44. PubMed ID: 17963189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimensional classification and behavioral pharmacology of personality disorders; a review and hypothesis.
    Tuinier S; Verhoeven WM
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):135-46. PubMed ID: 7549456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.